D-dimer from central and peripheral blood samples in asymptomatic central venous catheter-related thrombosis in patients with cancer

Abstract

Objectives

To evaluate the usefulness of a negative D-dimer in peripheral or central venous blood to screen for asymptomatic catheter-related thrombosis in cancer patients.

Methods

D-dimer was measured in blood from central venous catheter and peripheral venous samples in 48 patients with cancer. Asymptomatic catheter-related thrombosis was identified via Doppler ultrasound. Bland and Altman’s limits of agreement analysis was used to compare sample sites. Sensitivity and specificity of D-dimer was calculated.

Results

Overall, 33 of the central samples and 32 of the peripheral samples had D-dimer levels below the cutoff (≥0.3 mg/l). Mean central D-dimer was 0.31 ± 0.35 mg/l; peripheral 0.24 ± 0.22 mg/l (p = 0.5). Bland–Altman plot showed that the two sample sites were not equivalent. Catheter-related thrombosis was demonstrated in five patients, and there were three false negatives. Peripheral D-dimer had a negative predictive value of 90.9%.

Conclusions

A negative D-dimer may be useful for screening asymptomatic catheter-related thrombosis in patients with cancer, but the central and peripheral sample sites are not equivalent.

Keywords

D-dimer deep vein thrombosis central venous catheter catheter-related thrombosis

Get full access to this article

View all access options for this article.

References

Anderson

Krasnow

Boyer

et al.

Hickman catheter clots: a common occurrence despite daily heparin flushing. Cancer Treat Rep 1987; 71: 651–653.

Bona

. Thrombotic complications of central venous catheters in cancer patients. Semin Thromb Hemost 1999; 25: 147–155.

Bona

. Central line thrombosis in patients with cancer. Curr Opin Pulm Med 2003; 9: 362–366.

Rooden

Tesselaar

Osanto

et al.

Deep vein thrombosis associated with central venous catheters – a review. J Thromb Haemost 2005; 3: 2409–2419.

Castaman

. Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors). Thromb Res 2016; 140: S89–S92.

Abrahm

Mullen

. A prospective study of prolonged central venous access in leukemia. JAMA 1982; 248: 2868–2873.

Press

Ramsey

Larson

et al.

Hickman catheter infections in patients with malignancies. Medicine 1984; 63: 189–200.

Carrier

Lee

Bates

et al.

Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients. Thromb Res 2008; 123: 177–183.

Merminod

Pellicciotta

Bounameaux

. Limited usefulness of D-dimer in suspected deep vein thrombosis of the upper extremities. Blood Coagul Fibrinolysis 2006; 17: 225–226.

10.

Debourdeau

Farge

Beckers

et al.

International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost 2013; 11: 71–80.

11.

Geerts

. Central venous catheter-related thrombosis. Hematology 2014; 1: 306–311.

12.

Lee

Levine

Butler

et al.

Incidence, risk factors, and outcomes of catheterrelated thrombosis in adult patients with cancer. J Clin Oncol 2006; 24: 1404–1408.

13.

Piran

Ngo

McDiarmid

et al.

Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients. Thromb Res 2014; 133: 30–33.

14.

Chopra

Anand

Hickner

et al.

Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and metaanalysis. Lancet 2013; 382: 311–325.

15.

Boddi

Villa

Chiostri

et al.

Incidence of ultrasound-detected asymptomatic long-term central vein catheter-related thrombosis and fibrin sheath in cancer patients. Eur J Haematol 2015; 95: 472–479.

16.

Lee

Kamphuisen

. Epidemiology and prevention of catheter-related thrombosis in patients with cancer. J Thromb Haemost 2012; 10: 1491–1499.

17.

Kearon

Comerota

et al.

Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S–e494S.

18.

Murray

Precious

Alikhan

. Catheter-related thrombosis in cancer patients. Br J Haematol 2013; 162: 748–757.

19.

Di Nisio

Van Sluis

Bossuyt

et al.

Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost 2010; 8: 684–692.

20.

Sartori

Migliaccio

Favaretto

et al.

D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis. Thromb Res 2015; 135: 673–678.

21.

Kleinjan

Di Nisio

Beyer-Westendorf

et al.

Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med 2014; 160: 451–457.

22.

van Es

Bleker

Di Nisio

et al.

A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients. Thromb Res 2016; 148: 59–62.

23.

Jansen

van der Straaten

Roest

et al.

Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis. Haematologica 2005; 90: 499–504.

24.

Zwicker

Connolly

Carrier

et al.

Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2014; 12: 796–800.